Robot-assisted ultrasound biopsy of the prostate
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a robot-assisted method to take prostate tissue samples using an ultrasound probe placed through the rectum. It may help patients and doctors get clearer biopsy results when there are early warning signs of prostate problems, before a cancer diagnosis is confirmed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for your first diagnostic prostate biopsy
- You have a concerning PSA blood test (PSA above 4) and/or a concerning rectal exam result
- You have NOT already been diagnosed with prostate cancer
- You have NOT had a prostate biopsy before
- You do not have anal narrowing that blocks the ultrasound probe
- Your bowel prep is adequate for the procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial enrolls adults who are being evaluated or treated for possible or confirmed prostate cancer and allows researchers to collect prostate tissue. It may help improve understanding of prostate cancer over the course of diagnosis and standard care.
This trial tests whether using a combined PSMA-PET/MRI and ultrasound navigation system during robot-assisted prostate removal can help the surgeon remove the cancer more completely while preserving surrounding tissue. It is for patients with early-stage prostate cancer that is just starting to spread outside the prostate.
This trial tests a computer model that learns from MRI scans to predict prostate cancer. If you have had a prostate MRI showing suspicious areas and are scheduled for a biopsy, joining may help improve how cancer is detected.
This trial is testing a new way to do prostate biopsies by combining MRI findings with a targeted biopsy on the same side as the suspicious area. It is for men who have not had a biopsy before and have a moderately high PSA level.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.